D.E. Shaw & Co
AGN

D.E. Shaw & Co’s Allergan plc AGN Stock Holding History

D.E. Shaw & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-32,300
Closed -$5.72M – 4384
2020
Q1 		$5.72M Sell
32,300
-209,300
-87% -$39.4M 0.01% 1374
2019
Q4 		$46.2M Sell
241,600
-80,000
-25% -$14.4M 0.05% 428
2019
Q3 		$54.1M Sell
321,600
-153,700
-32% -$25M 0.07% 362
2019
Q2 		$79.6M Buy
475,300
+103,200
+28% +$14.3M 0.1% 248
2019
Q1 		$54.5M Sell
372,100
-63,800
-15% -$9.25M 0.07% 351
2018
Q4 		$58.3M Buy
435,900
+57,900
+15% +$9.49M 0.08% 299
2018
Q3 		$72M Sell
378,000
-156,200
-29% -$28.7M 0.09% 282
2018
Q2 		$89.1M Sell
534,200
-297,000
-36% -$47.7M 0.12% 204
2018
Q1 		$140M Sell
831,200
-91,500
-10% -$15.3M 0.19% 113
2017
Q4 		$151M Buy
922,700
+637,900
+224% +$114M 0.21% 97
2017
Q3 		$58.4M Buy
284,800
+115,000
+68% +$26.7M 0.09% 277
2017
Q2 		$41.3M Sell
169,800
-97,700
-37% -$23M 0.07% 341
2017
Q1 		$63.9M Sell
267,500
-54,200
-17% -$12.6M 0.11% 218
2016
Q4 		$67.6M Sell
321,700
-112,800
-26% -$23.4M 0.11% 204
2016
Q3 		$100M Buy
434,500
+105,500
+32% +$25.8M 0.18% 124
2016
Q2 		$76M Buy
329,000
+97,900
+42% +$22.6M 0.14% 162
2016
Q1 		$61.9M Sell
231,100
-30,445
-12% -$8.72M 0.11% 217
2015
Q4 		$81.7M Sell
261,545
-15,000
-5% -$4.47M 0.12% 187
2015
Q3 		$75.2M Buy
276,545
+39,800
+17% +$12.2M 0.11% 217
2015
Q2 		$71.8M Sell
236,745
-3,300
-1% -$984K 0.11% 228
2015
Q1 		$71.4M Sell
240,045
-206,360
-46% -$58.8M 0.11% 211
2014
Q4 		$115M Buy
446,405
+3,000
+0.7% +$750K 0.15% 145
2014
Q3 		$107M Buy
443,405
+87,505
+25% +$19.6M 0.14% 160
2014
Q2 		$79.4M Buy
355,900
+18,000
+5% +$3.73M 0.11% 216
2014
Q1 		$69.6M Sell
337,900
-14,800
-4% -$2.93M 0.1% 213
2013
Q4 		$59.3M Buy
352,700
+115,000
+48% +$18M 0.08% 262
2013
Q3 		$34.2M Buy
237,700
+113,200
+91% +$15.1M 0.05% 377
2013
Q2 		$15.7M Buy
+124,500
New +$14.1M 0.03% 627

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

D.E. Shaw & Co's AGN Position: Q2 2020 in Review

D.E. Shaw & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 461,899 shares — an estimated $81.8M sold.

D.E. Shaw & Co first reported a position in AGN in Q3 2013 and held it in 27 quarters. The position peaked at $614M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • D.E. Shaw & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 461,899 Allergan plc shares in Q2 2020, an estimated $81.8M.
  • D.E. Shaw & Co first reported a position in Allergan plc in Q3 2013 and held it in 27 quarters.
  • D.E. Shaw & Co's Allergan plc position peaked at $614M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on D.E. Shaw & Co's 13F filing for Q2 2020, filed 14 Aug 2020.